June marks a significant time of the year for millions worldwide as we come together to raise awareness and support for those affected by Amyotrophic Lateral Sclerosis (ALS). ALS, often referred to as Lou Gehrig’s Disease, is a progressive neurodegenerative disease that impacts nerve cells in the brain and spinal cord, leading to muscle weakness, loss of motor function, and ultimately, paralysis. With no known cure and limited treatment options, ALS poses a profound challenge to both patients and their families. However, June offers an opportunity to highlight the ongoing efforts to understand, treat, and ultimately cure this devastating disease.
Understanding ALS
ALS affects the neurons responsible for voluntary muscle movement. As these neurons degenerate, the brain’s ability to initiate and control muscle movement is lost. Early symptoms often include muscle twitching, cramping, and weakness in a limb or slurred speech. Over time, ALS patients experience increasing difficulty in speaking, swallowing, and breathing, which can lead to complete paralysis.
While the exact cause of ALS remains unclear, research suggests a combination of genetic and environmental factors. Approximately 5-10% of cases are familial, meaning they are inherited from a parent. The remaining cases are sporadic, occurring without a family history of the disease. Scientists continue to explore the genetic and molecular mechanisms underlying ALS, hoping to unlock new pathways for treatment.
ALS Symptoms in Women: What to Know
Most descriptions of early ALS symptoms have historically been drawn from studies of predominantly male populations. Emerging research suggests that ALS can present differently in women, and this difference is clinically meaningful for early recognition.
Women are more likely to experience bulbar-onset ALS, in which the first symptoms involve the muscles controlling speech and swallowing rather than the arms or legs. This can appear as progressive slurring of speech, a voice that tires quickly, or increasing difficulty swallowing. Because these symptoms overlap with other conditions, bulbar-onset ALS is sometimes delayed in diagnosis.
If you or someone you know is experiencing unexplained, persistent changes in speech, swallowing, or voice, bring it to a doctor’s attention. Early referral matters.
The Importance of Awareness
ALS Awareness Month is crucial for several reasons:
- Education and Understanding: Increasing public knowledge about ALS can lead to earlier diagnosis and better support for patients and caregivers. Understanding the symptoms and progression of ALS helps demystify the disease, reducing stigma and fostering empathy.
- Funding for Research: Raising awareness often translates into increased funding for research. Donations and fundraising events during June support critical studies aimed at finding treatments and ultimately a cure. The Ice Bucket Challenge of 2014, for example, significantly boosted ALS research funding and brought the disease into the global spotlight.
- Support for Patients and Families: Awareness initiatives highlight the need for comprehensive care and support systems for those affected by ALS. From medical assistance to emotional and financial support, raising awareness helps build a network of resources for patients and their families.
How Centrum Pharmacy Stands with ALS Patients and Families
At Centrum Pharmacy, we are dedicated to standing by ALS patients and their families every step of the way. Here’s how we’re making a difference:
- Comprehensive Care: We provide a wide range of pharmaceutical services tailored to the unique needs of ALS patients. Our pharmacists are trained to offer expert advice on medication management, side effects, and drug interactions, ensuring that patients receive the best possible care.
- Support and Resources: We understand that ALS affects more than just the patient—it impacts entire families. That’s why we offer resources and support to help caregivers manage their loved ones’ care more effectively. From educational materials to one-on-one consultations, we’re here to support you.
- Community Engagement: Centrum Pharmacy actively participates in and sponsors local ALS awareness events and fundraisers. We believe in the power of community and are committed to raising both awareness and funds to support ongoing research and patient care.
- Accessibility and Convenience: We strive to make medication access as easy as possible for ALS patients and their families. Our delivery services ensure that you can receive your medications without leaving the comfort of your home, reducing stress and ensuring continuity of care.
- Personalized Service: We take the time to get to know our patients and their specific needs. This personalized approach allows us to provide more effective care and build strong, trusting relationships with those we serve.
What’s New in ALS Treatment
The treatment landscape for ALS has changed meaningfully in the past few years, and Canadian patients now have more options than were available even at the time of the Ice Bucket Challenge.
Riluzole (Rilutek) remains the foundational disease-modifying therapy, extending survival by slowing glutamate-mediated nerve cell damage. Edaravone (Radicava) is an antioxidant therapy approved in Canada that may slow functional decline, particularly in earlier-stage patients.
The most significant recent development is tofersen (Qalsody), approved by Health Canada for patients with ALS caused by mutations in the SOD1 gene. It is the first targeted therapy for a specific genetic subtype of ALS — a milestone in a disease that has historically had very limited treatment options. Tofersen works by reducing production of the mutant SOD1 protein and is administered by intrathecal injection under specialist supervision.
AMX0035 (Albrioza) has also received conditional approval in Canada. This combination therapy targets multiple cell death pathways and may slow functional decline in some patients.
As these treatments involve complex administration schedules, storage requirements, and monitoring needs, pharmacist involvement in ALS medication management is more important than ever. At Centrum Pharmacy, our team can help navigate medication reviews, flag interactions, and coordinate with your prescribing team when treatment changes.
How You Can Make a Difference
There are numerous ways to contribute to ALS Awareness Month and support the fight against this disease:
- Participate in Fundraising Events: Many organizations host events such as walks, runs, and bike rides to raise funds for ALS research. Participating in or donating to these events can make a significant impact.
- Social Media Advocacy: Use your social media platforms to spread awareness. Share facts about ALS, stories of those affected, and information about how others can help. Hashtags like #ALSawareness and #EndALS can amplify your message.
- Volunteer: Many ALS associations and foundations rely on volunteers to help with events, patient support, and administrative tasks. Offering your time can provide much-needed assistance and contribute to the cause.
- Educate Yourself and Others: Take the time to learn about ALS and share your knowledge with friends, family, and colleagues. Education is a powerful tool in the fight against this disease.
- Support Research: Consider donating to reputable organizations dedicated to ALS research. Your contribution can help fund critical studies that may lead to breakthroughs in understanding and treating ALS.
Looking Ahead with Hope
While ALS remains a formidable challenge, the advancements in research and the growing global awareness provide hope. Each June, we are reminded of the strength and resilience of the ALS community and the tireless efforts of researchers, healthcare professionals, and advocates working towards a world without ALS. By coming together, we can make a difference, one step at a time.
Centrum Pharmacy is proud to be part of this journey, standing with ALS patients and their families not just in June, but every month of the year. Let’s use this month to honor those affected by ALS, support ongoing research, and spread hope for a future free from this devastating disease. Together, we can help turn ALS from an incurable condition into a treatable one, and ultimately, a curable one. Join the fight against ALS this June and make your impact.
Frequently Asked Questions
Early ALS symptoms vary by where in the nervous system the disease begins. Limb-onset ALS typically starts with unexplained muscle weakness in a hand, arm, foot, or leg, along with muscle twitching and cramping. Bulbar-onset ALS, which is more common in women, begins with changes to speech and swallowing — slurred speech, a voice that tires quickly, or difficulty swallowing. Because early symptoms are subtle and overlap with other conditions, they are often attributed to something else for months before a diagnosis is reached.
Yes. Research suggests women are more likely than men to experience bulbar-onset ALS, in which speech and swallowing are affected first rather than the limbs. This distinction matters because bulbar symptoms are easier to attribute to other causes, potentially delaying diagnosis. Awareness of this difference can lead to earlier referral and faster access to specialist care.
Several treatments are approved in Canada. Riluzole (Rilutek) has been the standard disease-modifying therapy for decades. Edaravone (Radicava) may slow functional decline in some patients. Tofersen (Qalsody) is a newer targeted therapy approved for patients with SOD1-gene ALS. AMX0035 (Albrioza) has received conditional approval and targets multiple cell death pathways. Beyond these, a range of medications addresses ALS symptoms including muscle spasticity, excess secretions, and swallowing difficulties.
Tofersen (Qalsody) is a targeted antisense oligonucleotide therapy approved by Health Canada for patients with ALS caused by mutations in the SOD1 gene. It works by reducing production of the mutant protein that drives neuronal damage in this subtype of ALS. It is administered by intrathecal injection under specialist supervision and is not appropriate for all ALS patients — only those with confirmed SOD1 mutations, which account for a subset of familial ALS cases.
ALS patients often manage multiple medications simultaneously, and as the disease progresses, dosing and delivery methods may need to change. A pharmacist can review your full medication profile for interactions, counsel on administration when swallowing becomes difficult, coordinate with your prescribing physicians, and provide continuity as your treatment plan evolves. At Centrum Pharmacy, our team is integrated with the Orléans Family Health Clinic, which means your pharmacist and your doctor are working from the same picture.
Approximately 5-10% of ALS cases are familial, meaning they are inherited. The remaining 90-95% are sporadic, occurring without a family history of the disease. Several genetic mutations have been identified in familial ALS, including in the SOD1, C9orf72, FUS, and TARDBP genes. Genetic testing and counselling are available for patients and families who want to understand their specific situation.
Stay Connected with Centrum Pharmacy!
If you found this article helpful, don’t forget to like, share, and Follow to stay up to date on our latest health tips, pharmacy updates, and wellness advice.
Come for the Convenience, Stay for the Service.
Caring for Your Family Since 1999
Disclaimer: The medical information on this site is provided as an information resource only and is not to be used or relied on for any diagnostic or treatment purposes. This information does not substitute for professional diagnosis and treatment. Please do not initiate, modify, or discontinue any treatment, medication, or supplement solely based on this information. Always seek the advice of your healthcare provider first. Full Disclaimer.
